Skip to content

A Multicenter Clinical Study on the Intervention of Kanli Granules in Heart Failure with Preserved Ejection Fraction

A Multicenter Clinical Study on the Intervention of Kanli Granules in Heart Failure with Preserved Ejection Fraction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000470
Enrollment
Unknown
Registered
2026-03-05
Start date
2025-11-24
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure with Preserved Ejection

Interventions

control group:Basic management
experiment group:Kanli Granules

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) The patient has been clearly diagnosed with heart failure with preserved ejection fraction (HFpEF) by Western medicine. 2) The patient has been clearly diagnosed with heart water disease (heart failure disease) - yang qi deficiency syndrome by Traditional Chinese Medicine. 3) The age range is between 30 and 80 years old. 4) The NYHA cardiac function classification is between grade II and IV. 5) The informed consent form is signed by the patient themselves or their legal guardian. 6) The patient has not participated in any other clinical trials or clinical research.

Exclusion criteria

Exclusion criteria: 1) Patients with combined malignant tumors, severe liver and kidney dysfunction, etc., with an expected survival of no more than one year; 2) Patients who need coronary artery bypass grafting at the same time; 3) Patients undergoing emergency surgery at the same time; 4) Patients with incomplete or excessive missing values in inpatient/outpatient electronic medical records and follow-up data; 5) Patients with a hospitalization period of less than or equal to 3 days and no physical, chemical or imaging examinations; 6) Pregnant or lactating women; 7) Patients with poor compliance or other reasons who cannot cooperate with clinical data collection.

Design outcomes

Primary

MeasureTime frame
NT-proBNP;

Secondary

MeasureTime frame
Traditional Chinese Medicine Syndrome Scoring and Therapeutic Efficacy;Cardiac Function Assessment;Minnesota Living with Heart Failure Questionnaire;Cardiac sonography;Laboratory parameters;

Countries

China

Contacts

Public ContactXiaofen Ruan

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

rxfzdl@163.com18018512332

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026